Large Granular Lymphocytic Leukemia : Common Therapies and their Outcomes
暂无分享,去创建一个
S. Mustjoki | J. Maciejewski | A. Jerez | A. Advani | M. Sekeres | H. Makishima | H. Husseinzadeh | B. Dienes | B. Pohlman | R. Tiu | A. Lichtin | H. Rajala | M. Clemente | M. Afable | Li Zhang | John Desamito | Holleh Husseinzadeh
[1] S. Mustjoki,et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. , 2012, Blood.
[2] T. Waldmann,et al. Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. , 2012, Blood.
[3] T. Loughran,et al. How I treat LGL leukemia. , 2011, Blood.
[4] J. Bennett,et al. Results of a Prospective Multicenter Phase II Study of Initial Treatment with Methotrexate In LGL Leukemia (ECOG Protocol E5998) , 2010 .
[5] T. Fest,et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases , 2010, Haematologica.
[6] M. Wlodarski,et al. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia , 2009, Haematologica.
[7] R. Albert,et al. Network model of survival signaling in large granular lymphocyte leukemia , 2008, Proceedings of the National Academy of Sciences.
[8] J. Maciejewski,et al. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. , 2008, Experimental Hematology.
[9] N. Young,et al. HLA‐DR4 predicts haematological response to cyclosporine in T‐large granular lymphocyte lymphoproliferative disorders , 2003, British journal of haematology.
[10] T. Loughran,et al. Survival signals in leukemic large granular lymphocytes. , 2003, Seminars in hematology.
[11] A. Berrebi,et al. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. , 2002, The hematology journal : the official journal of the European Haematology Association.
[12] J. Melenhorst,et al. Large granular lymphocyte leukaemia is characterized by a clonal T‐cell receptor rearrangement in both memory and effector CD8+ lymphocyte populations , 2001, British journal of haematology.
[13] F. Raffi,et al. Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. , 2000, The American journal of medicine.
[14] J. H. Liu,et al. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. , 1998, Blood.
[15] T. Loughran,et al. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. , 1994, Blood.
[16] M. Dhodapkar,et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? , 1994, Blood.